Accuray ROE 2010-2025 | ARAY

Current and historical return on equity (ROE) values for Accuray (ARAY) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Accuray ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-03-31 $0.00B $0.05B 2.13%
2024-12-31 $0.00B $0.05B -8.94%
2024-09-30 $-0.02B $0.05B -37.99%
2024-06-30 $-0.02B $0.05B -34.59%
2024-03-31 $-0.02B $0.04B -45.36%
2023-12-31 $-0.02B $0.05B -28.85%
2023-09-30 $-0.01B $0.05B -13.21%
2023-06-30 $-0.01B $0.05B -17.31%
2023-03-31 $-0.01B $0.06B -17.39%
2022-12-31 $-0.01B $0.05B -21.57%
2022-09-30 $-0.01B $0.05B -17.73%
2022-06-30 $-0.01B $0.05B -9.90%
2022-03-31 $-0.01B $0.05B -23.85%
2021-12-31 $-0.01B $0.05B -19.59%
2021-09-30 $-0.01B $0.05B -10.29%
2021-06-30 $-0.01B $0.07B -8.19%
2021-03-31 $0.01B $0.08B 6.94%
2020-12-31 $0.01B $0.08B 11.90%
2020-09-30 $0.01B $0.07B 22.67%
2020-06-30 $0.01B $0.06B 9.05%
2020-03-31 $0.00B $0.06B 7.73%
2019-12-31 $0.00B $0.06B 0.00%
2019-09-30 $-0.02B $0.04B -34.59%
2019-06-30 $-0.02B $0.05B -33.51%
2019-03-31 $-0.02B $0.05B -33.68%
2018-12-31 $-0.02B $0.05B -51.34%
2018-09-30 $-0.02B $0.05B -50.53%
2018-06-30 $-0.02B $0.05B -50.00%
2018-03-31 $-0.03B $0.05B -58.95%
2017-12-31 $-0.02B $0.05B -50.53%
2017-09-30 $-0.03B $0.05B -59.57%
2017-06-30 $-0.03B $0.05B -60.42%
2017-03-31 $-0.03B $0.05B -60.49%
2016-12-31 $-0.03B $0.05B -45.05%
2016-09-30 $-0.02B $0.05B -37.29%
2016-06-30 $-0.03B $0.06B -40.49%
2016-03-31 $-0.02B $0.06B -36.50%
2015-12-31 $-0.03B $0.06B -40.43%
2015-09-30 $-0.03B $0.06B -43.84%
2015-06-30 $-0.04B $0.08B -53.25%
2015-03-31 $-0.05B $0.08B -54.38%
2014-12-31 $-0.05B $0.08B -53.56%
2014-09-30 $-0.04B $0.08B -45.41%
2014-06-30 $-0.04B $0.10B -37.40%
2014-03-31 $-0.05B $0.10B -45.80%
2013-12-31 $-0.07B $0.10B -67.78%
2013-09-30 $-0.10B $0.10B -80.00%
2013-06-30 $-0.10B $0.11B -75.05%
2013-03-31 $-0.10B $0.12B -64.40%
2012-12-31 $-0.09B $0.15B -47.50%
2012-09-30 $-0.07B $0.17B -33.62%
2012-06-30 $-0.07B $0.20B -32.32%
2012-03-31 $-0.08B $0.22B -33.23%
2011-12-31 $-0.06B $0.23B -28.35%
2011-09-30 $-0.05B $0.24B -23.44%
2011-06-30 $-0.03B $0.24B -14.10%
2011-03-31 $0.00B $0.18B 1.72%
2010-12-31 $0.01B $0.18B 3.53%
2010-09-30 $0.00B $0.17B 0.61%
2010-06-30 $0.00B $0.17B 1.86%
2010-03-31 $0.00B $0.16B -0.64%
2009-12-31 $0.00B $0.16B -1.31%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.151B $0.447B
Accuray Inc. designs, develops & sells radiosurgery and radiation therapy systems for treatment of tumors in the body. The company's product suite includes the CyberKnife Systems and the TomoTherapy Systems. It primarily generates revenues by selling the CyberKnife & TomoTherapy Systems and providing ongoing services and upgrades to customers following installation of the CyberKnife System. Product revenues include sales of linacs for other uses. It also offers optional hardware and software, technical enhancements and upgrades to the CyberKnife & TomoTherapy System. The CyberKnife Systems include: the CyberKnife G4, CyberKnife VSI System and the new CyberKnife M6 Series System. TomoTherapy Systems include the Hi-Art System, delivering CT-guided, helical intensity modulated radiation therapy; the TomoHD System and the Tomo H Series Systems.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $180.170B 21.80
Intuitive Surgical (ISRG) United States $179.421B 74.37
Edwards Lifesciences (EW) United States $47.608B 31.58
IDEXX Laboratories (IDXX) United States $46.009B 52.87
Alcon (ALC) Switzerland $43.988B 29.73
DexCom (DXCM) United States $34.921B 52.39
IQVIA Holdings (IQV) United States $32.562B 18.40
Mettler-Toledo (MTD) United States $26.309B 31.29
STERIS (STE) Ireland $22.554B 24.84
Waters (WAT) United States $17.797B 25.11
SONOVA HOLDING (SONVY) Switzerland $16.385B 0.00
Hologic (HOLX) United States $14.480B 15.66
Sysmex ADR (SSMXY) Japan $10.386B 29.46
Penumbra (PEN) United States $9.845B 72.42
Masimo (MASI) United States $8.459B 31.20
Globus Medical (GMED) United States $7.236B 17.24
Glaukos (GKOS) United States $5.374B 0.00
Teleflex (TFX) United States $5.034B 8.31
Integer Holdings (ITGR) United States $3.810B 19.01
TransMedics (TMDX) United States $3.643B 55.80
PROCEPT BioRobotics (PRCT) United States $2.841B 0.00
LivaNova (LIVN) United Kingdom $2.400B 14.29
Nihon Kohden (NHNKY) Japan $1.956B 22.43
Elekta AB (EKTAY) Sweden $1.903B 17.10
Veracyte (VCYT) United States $1.877B 26.34
Alphatec Holdings (ATEC) United States $1.568B 0.00
Artivion (AORT) United States $1.348B 126.28
Tandem Diabetes Care (TNDM) United States $1.110B 0.00
OPKO Health (OPK) United States $1.063B 0.00
Pulse Biosciences (PLSE) United States $0.991B 0.00
Integra LifeSciences Holdings (IART) United States $0.961B 5.11
SiBone (SIBN) United States $0.759B 0.00
IRadimed (IRMD) United States $0.742B 37.66
Beta Bionics (BBNX) United States $0.727B 0.00
AxoGen (AXGN) United States $0.601B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.540B 8.40
OrthoPediatrics (KIDS) United States $0.527B 0.00
Semler Scientific (SMLR) United States $0.495B 10.66
Pacific Biosciences Of California (PACB) United States $0.447B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.445B 0.00
Mesa Laboratories (MLAB) United States $0.434B 10.08
Delcath Systems (DCTH) United States $0.381B 0.00
AngioDynamics (ANGO) United States $0.364B 0.00
Treace Medical Concepts (TMCI) United States $0.348B 0.00
RxSight (RXST) United States $0.324B 0.00
ClearPoint Neuro (CLPT) United States $0.298B 0.00
Neuronetics (STIM) United States $0.294B 0.00
NeuroPace (NPCE) United States $0.287B 0.00
Alpha Tau Medical (DRTS) Israel $0.246B 0.00
908 Devices (MASS) United States $0.244B 0.00
Tactile Systems Technology (TCMD) United States $0.236B 14.30
CVRx (CVRX) United States $0.215B 0.00
Monogram Orthopaedics (MGRM) United States $0.200B 0.00
Sight Sciences (SGHT) United States $0.178B 0.00
Inogen (INGN) United States $0.176B 0.00
Spectral Diagnostics (EDTXF) Canada $0.174B 0.00
Rapid Micro Biosystems (RPID) United States $0.166B 0.00
LENSAR (LNSR) United States $0.156B 0.00
Biosig Technologies (BSGM) United States $0.123B 0.00
Anteris Technologies Global (AVR) Australia $0.120B 0.00
Atossa Genetics (ATOS) United States $0.113B 0.00
Lucid Diagnostics (LUCD) United States $0.109B 0.00
Microbot Medical (MBOT) United States $0.094B 0.00
Sensus Healthcare (SRTS) United States $0.087B 52.90
EnVVeno Medical (NVNO) United States $0.085B 0.00
Hyperfine (HYPR) United States $0.079B 0.00
InspireMD (NSPR) United States $0.073B 0.00
Spectral AI (MDAI) United States $0.062B 0.00
Positron (POSC) United States $0.061B 0.00
QT Imaging Holdings (QTIH) United States $0.055B 0.00
EDAP TMS S.A (EDAP) France $0.053B 0.00
Vicarious Surgical (RBOT) United States $0.051B 0.00
Covalon Technologies (CVALF) Canada $0.050B 20.33
WORK Medical Technology Group (WOK) China $0.044B 0.00
Precision Optics (POCI) United States $0.036B 0.00
Envoy Medical (COCH) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.026B 0.00
Adagio Medical Holdings (ADGM) United States $0.021B 0.00
NexGel (NXGL) United States $0.017B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
Baird Medical Investment Holdings (BDMD) $0.014B 0.00
PAVmed (PAVM) United States $0.010B 0.00
Ekso Bionics Holdings (EKSO) United States $0.009B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.006B 0.00
ReShape Lifesciences (RSLS) United States $0.006B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.001B 0.00
Helius Medical Technologies (HSDT) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 14.74
Longview Acquisition II (LGV) United States $0.000B 0.00